Company intelligence / Profile preview

Eng3

Seattle, Washington, United States
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Eng3 Corporation is a Seattle-based biotechnology company that develops and manufactures the NanoVi device, a non-invasive technology designed to enhance cellular repair. The technology works by generating a specific electromagnetic signal that influences the structure of water to facilitate protein folding and mitigate damage caused by oxidative stress. NanoVi is widely utilized in sports medicine, anti-aging clinics, and by individuals seeking to improve recovery times and overall cellular health. The company's approach is unique in that it does not rely on supplements or drugs, but rather on biophysical signaling to support the body's natural regenerative processes. Eng3 serves a global market, providing solutions for both professional performance and general wellness.

Therapeutic areas
NeurologyOtherMetabolic Disorders
Modalities
DeviceNon-pharmacological therapy
Industry
Therapeutic Medical Devices

Beyond the preview

Go deeper on Eng3.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eng3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call